Validation of the Arabic version of calgary depression scale for schizophrenia

Yahya Hani, Suhaila Ghuloum, Ziyad Mahfoud, Mark Opler, Anzalee Khan, Arij Yehya, Abdulmoneim Abdulhakam, Samer Hammoudeh, Azza Al-Mujalli, Reem Elsherbiny, Hassen Al Amin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background Patients with schizophrenia commonly show both depressive and negative symptoms that can differentially affect the prognosis and course of treatment. The Calgary Depression Scale for Schizophrenia (CDSS) was designed to distinguish between depression and negative symptoms in patients with schizophrenia. The purpose of this study is to validate an Arabic version of the CDSS among patients with schizophrenia. Methods The diagnosis of schizophrenia was confirmed using the Arabic Mini International Neuropsychiatric Interview 6 (MINI 6). A standardized translation back-translation process was adopted. One rater administered the Arabic CDSS to subjects with schizophrenia as well as to a control group who should not have any psychiatric disorder except for depression. Another rater, blinded to the results administered the already validated Arabic version of Beck Depression Inventory-II (BDI-II). Results We recruited 102 patients and 102 controls subjects. The CDSS showed good internal consistency in the active group (Cronbach's alpha = 0.82). The Intraclass Coefficient correlations (ICC) for the inter-rater reliability (n = 21) was 0.90, p<0.05 and test-retest reliability (n = 19) was 0.85, p<0.001. When compared to the BDI-II, the cutoff score of 5 on the Arabic CDSS showed reasonable sensitivity and specificity of 72.75% and 67.95% respectively. Conclusions The psychometric properties of the Arabic version of CDSS demonstrate that it is a valid tool to assess the depressive symptoms in the Arab patients with schizophrenia.

Original languageEnglish
Article numbere0162304
JournalPLoS One
Volume11
Issue number9
DOIs
Publication statusPublished - 1 Sep 2016

Fingerprint

Schizophrenia
Depression
signs and symptoms (animals and humans)
schizophrenia
Arabs
Equipment and Supplies
behavior disorders
Psychometrics
Reproducibility of Results
prognosis
Psychiatry
interviews
Interviews
Sensitivity and Specificity
Control Groups

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Hani, Y., Ghuloum, S., Mahfoud, Z., Opler, M., Khan, A., Yehya, A., ... Al Amin, H. (2016). Validation of the Arabic version of calgary depression scale for schizophrenia. PLoS One, 11(9), [e0162304]. https://doi.org/10.1371/journal.pone.0162304

Validation of the Arabic version of calgary depression scale for schizophrenia. / Hani, Yahya; Ghuloum, Suhaila; Mahfoud, Ziyad; Opler, Mark; Khan, Anzalee; Yehya, Arij; Abdulhakam, Abdulmoneim; Hammoudeh, Samer; Al-Mujalli, Azza; Elsherbiny, Reem; Al Amin, Hassen.

In: PLoS One, Vol. 11, No. 9, e0162304, 01.09.2016.

Research output: Contribution to journalArticle

Hani, Y, Ghuloum, S, Mahfoud, Z, Opler, M, Khan, A, Yehya, A, Abdulhakam, A, Hammoudeh, S, Al-Mujalli, A, Elsherbiny, R & Al Amin, H 2016, 'Validation of the Arabic version of calgary depression scale for schizophrenia', PLoS One, vol. 11, no. 9, e0162304. https://doi.org/10.1371/journal.pone.0162304
Hani Y, Ghuloum S, Mahfoud Z, Opler M, Khan A, Yehya A et al. Validation of the Arabic version of calgary depression scale for schizophrenia. PLoS One. 2016 Sep 1;11(9). e0162304. https://doi.org/10.1371/journal.pone.0162304
Hani, Yahya ; Ghuloum, Suhaila ; Mahfoud, Ziyad ; Opler, Mark ; Khan, Anzalee ; Yehya, Arij ; Abdulhakam, Abdulmoneim ; Hammoudeh, Samer ; Al-Mujalli, Azza ; Elsherbiny, Reem ; Al Amin, Hassen. / Validation of the Arabic version of calgary depression scale for schizophrenia. In: PLoS One. 2016 ; Vol. 11, No. 9.
@article{a797ce54e5b84445897a3a91753e3640,
title = "Validation of the Arabic version of calgary depression scale for schizophrenia",
abstract = "Background Patients with schizophrenia commonly show both depressive and negative symptoms that can differentially affect the prognosis and course of treatment. The Calgary Depression Scale for Schizophrenia (CDSS) was designed to distinguish between depression and negative symptoms in patients with schizophrenia. The purpose of this study is to validate an Arabic version of the CDSS among patients with schizophrenia. Methods The diagnosis of schizophrenia was confirmed using the Arabic Mini International Neuropsychiatric Interview 6 (MINI 6). A standardized translation back-translation process was adopted. One rater administered the Arabic CDSS to subjects with schizophrenia as well as to a control group who should not have any psychiatric disorder except for depression. Another rater, blinded to the results administered the already validated Arabic version of Beck Depression Inventory-II (BDI-II). Results We recruited 102 patients and 102 controls subjects. The CDSS showed good internal consistency in the active group (Cronbach's alpha = 0.82). The Intraclass Coefficient correlations (ICC) for the inter-rater reliability (n = 21) was 0.90, p<0.05 and test-retest reliability (n = 19) was 0.85, p<0.001. When compared to the BDI-II, the cutoff score of 5 on the Arabic CDSS showed reasonable sensitivity and specificity of 72.75{\%} and 67.95{\%} respectively. Conclusions The psychometric properties of the Arabic version of CDSS demonstrate that it is a valid tool to assess the depressive symptoms in the Arab patients with schizophrenia.",
author = "Yahya Hani and Suhaila Ghuloum and Ziyad Mahfoud and Mark Opler and Anzalee Khan and Arij Yehya and Abdulmoneim Abdulhakam and Samer Hammoudeh and Azza Al-Mujalli and Reem Elsherbiny and {Al Amin}, Hassen",
year = "2016",
month = "9",
day = "1",
doi = "10.1371/journal.pone.0162304",
language = "English",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - Validation of the Arabic version of calgary depression scale for schizophrenia

AU - Hani, Yahya

AU - Ghuloum, Suhaila

AU - Mahfoud, Ziyad

AU - Opler, Mark

AU - Khan, Anzalee

AU - Yehya, Arij

AU - Abdulhakam, Abdulmoneim

AU - Hammoudeh, Samer

AU - Al-Mujalli, Azza

AU - Elsherbiny, Reem

AU - Al Amin, Hassen

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Background Patients with schizophrenia commonly show both depressive and negative symptoms that can differentially affect the prognosis and course of treatment. The Calgary Depression Scale for Schizophrenia (CDSS) was designed to distinguish between depression and negative symptoms in patients with schizophrenia. The purpose of this study is to validate an Arabic version of the CDSS among patients with schizophrenia. Methods The diagnosis of schizophrenia was confirmed using the Arabic Mini International Neuropsychiatric Interview 6 (MINI 6). A standardized translation back-translation process was adopted. One rater administered the Arabic CDSS to subjects with schizophrenia as well as to a control group who should not have any psychiatric disorder except for depression. Another rater, blinded to the results administered the already validated Arabic version of Beck Depression Inventory-II (BDI-II). Results We recruited 102 patients and 102 controls subjects. The CDSS showed good internal consistency in the active group (Cronbach's alpha = 0.82). The Intraclass Coefficient correlations (ICC) for the inter-rater reliability (n = 21) was 0.90, p<0.05 and test-retest reliability (n = 19) was 0.85, p<0.001. When compared to the BDI-II, the cutoff score of 5 on the Arabic CDSS showed reasonable sensitivity and specificity of 72.75% and 67.95% respectively. Conclusions The psychometric properties of the Arabic version of CDSS demonstrate that it is a valid tool to assess the depressive symptoms in the Arab patients with schizophrenia.

AB - Background Patients with schizophrenia commonly show both depressive and negative symptoms that can differentially affect the prognosis and course of treatment. The Calgary Depression Scale for Schizophrenia (CDSS) was designed to distinguish between depression and negative symptoms in patients with schizophrenia. The purpose of this study is to validate an Arabic version of the CDSS among patients with schizophrenia. Methods The diagnosis of schizophrenia was confirmed using the Arabic Mini International Neuropsychiatric Interview 6 (MINI 6). A standardized translation back-translation process was adopted. One rater administered the Arabic CDSS to subjects with schizophrenia as well as to a control group who should not have any psychiatric disorder except for depression. Another rater, blinded to the results administered the already validated Arabic version of Beck Depression Inventory-II (BDI-II). Results We recruited 102 patients and 102 controls subjects. The CDSS showed good internal consistency in the active group (Cronbach's alpha = 0.82). The Intraclass Coefficient correlations (ICC) for the inter-rater reliability (n = 21) was 0.90, p<0.05 and test-retest reliability (n = 19) was 0.85, p<0.001. When compared to the BDI-II, the cutoff score of 5 on the Arabic CDSS showed reasonable sensitivity and specificity of 72.75% and 67.95% respectively. Conclusions The psychometric properties of the Arabic version of CDSS demonstrate that it is a valid tool to assess the depressive symptoms in the Arab patients with schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=84990961172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990961172&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0162304

DO - 10.1371/journal.pone.0162304

M3 - Article

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e0162304

ER -